NCT05918692
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05918692
Title A Phase 1 Study of BMF-500 in Adults With Acute Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Biomea Fusion Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
City of Hope National Medical Center Duarte California 91010 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322 United States Details
Northwestern Memorial Hospital Chicago Illinois 60611 United States Details
University of Kentucky - Markey Cancer Center Lexington Kentucky 40536 United States Details
Mayo Clinic Rochester Minnesota 55902 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14203 United States Details
Texas Oncology-PA USOR Dallas Texas 75251 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Cancer Specialists Gainesville Virginia 20155 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field